<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270143" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12101909</article-id><article-id pub-id-type="doi">10.1002/deo2.70143</article-id><article-id pub-id-type="publisher-id">DEO270143</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Covered Self&#x02010;Expanding Metal Stents Versus Multiple Plastic Stents in Treating Biliary Strictures Post&#x02010;Orthotopic Liver Transplantation: A Systematic Review and Meta&#x02010;Analysis of Randomized Controlled Trials</article-title></title-group><contrib-group><contrib id="deo270143-cr-0001" contrib-type="author" corresp="yes"><name><surname>Rocha Fernandes</surname><given-names>Ygor</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8653-8658</contrib-id><xref rid="deo270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>ygorrfernandes@gmail.com</email></address></contrib><contrib id="deo270143-cr-0002" contrib-type="author"><name><surname>Visconti</surname><given-names>Thiago Arantes de Carvalho</given-names></name><xref rid="deo270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270143-cr-0003" contrib-type="author"><name><surname>Dall'Agnol</surname><given-names>Marcelo Klotz</given-names></name><xref rid="deo270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270143-cr-0004" contrib-type="author"><name><surname>Ardengh</surname><given-names>Andr&#x000e9; Orsini</given-names></name><xref rid="deo270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270143-cr-0005" contrib-type="author"><name><surname>Veras</surname><given-names>Matheus de Oliveira</given-names></name><xref rid="deo270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270143-cr-0006" contrib-type="author"><name><surname>Valentim</surname><given-names>Evellin Souza dos Santos</given-names></name><xref rid="deo270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270143-cr-0007" contrib-type="author"><name><surname>Lera dos Santos</surname><given-names>Marcos Eduardo</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9759-3807</contrib-id><xref rid="deo270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270143-cr-0008" contrib-type="author"><name><surname>Matuguma</surname><given-names>Sergio Eiji</given-names></name><xref rid="deo270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270143-cr-0009" contrib-type="author"><name><surname>Bernardo</surname><given-names>Wanderley Marques</given-names></name><xref rid="deo270143-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="deo270143-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo270143-cr-0010" contrib-type="author"><name><surname>de Moura</surname><given-names>Eduardo Guimar&#x000e3;es Hourneaux</given-names></name><xref rid="deo270143-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="deo270143-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="deo270143-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<named-content content-type="organisation-division">Hospital das Cl&#x000ed;nicas</named-content>
<institution>University of S&#x000e3;o Paulo Medical School (HCFMUSP)</institution>
<city>Sao Paulo</city>
<country country="BR">Brazil</country>
</aff><aff id="deo270143-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Faculty of Medicine</named-content>
<institution>University of S&#x000e3;o Paulo</institution>
<city>Sao Paulo</city>
<country country="BR">Brazil</country>
</aff><aff id="deo270143-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Medical Guidelines Program, Brazilian Medical Association</institution>
<city>Sao Paulo</city>
<country country="BR">Brazil</country>
</aff><aff id="deo270143-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Gastrointestinal Endoscopy Unit</named-content>
<institution>Clinical Hospital of Faculty of Medicine of the University of S&#x000e3;o Paulo</institution>
<city>Sao Paulo</city>
<country country="BR">Brazil</country>
</aff><aff id="deo270143-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>Graduate Program in Gastroenterology</institution>
<institution>Faculty of Medicine of the University of S&#x000e3;o Paulo</institution>
<city>Sao Paulo</city>
<country country="BR">Brazil</country>
</aff><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2026</year></pub-date><volume>6</volume><issue seq="4730">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v6.1</issue-id><elocation-id>e70143</elocation-id><history>
<date date-type="rev-recd"><day>24</day><month>4</month><year>2025</year></date>
<date date-type="received"><day>15</day><month>1</month><year>2025</year></date>
<date date-type="accepted"><day>30</day><month>4</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2026 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-6-e70143.pdf"/><abstract><title>ABSTRACT</title><sec id="deo270143-sec-0010"><title>Objectives</title><p>Anastomotic biliary strictures are a common complication following orthotopic liver transplantation (post&#x02010;OLT), impacting morbidity and graft survival. This meta&#x02010;analysis evaluates the efficacy, safety, and cost&#x02010;effectiveness of covered self&#x02010;expanding metal stents (cSEMS) versus multiple plastic stents (MPS) for treating post&#x02010;OLT strictures.</p></sec><sec id="deo270143-sec-0020"><title>Methods</title><p>A systematic review was conducted in PubMed, Cochrane Central, Embase, Scholar, and SciELO. We analyzed randomized controlled trials (RCTs) comparing cSEMS and MPS in post&#x02010;OLT biliary strictures. Outcomes included stricture resolution, recurrence, endoscopic retrograde cholangiopancreatography sessions, adverse events, and cost. Standardized mean differences (SMDs) and risk ratios (RRs) were calculated with 95% confidence intervals (CIs). Cost&#x02010;effectiveness analysis covered direct and indirect expenses.</p></sec><sec id="deo270143-sec-0030"><title>Results</title><p>Five RCTs with 269 patients were analyzed. No significant differences were found between cSEMS and MPS in terms of stricture resolution (RR&#x000a0;=&#x000a0;1.01; 95% CI [0.90, 1.13]; <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.91), recurrence rates (RR&#x000a0;=&#x000a0;2.23; 95% CI [0.74, 6.75]; <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.15), adverse events (RR&#x000a0;=&#x000a0;0.80; 95% CI [0.41, 1.54]; <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.50), stent migration (RR&#x000a0;=&#x000a0;1.55; 95% CI [0.69, 3.50]; <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.29), number of endoscopic retrograde cholangiopancreatography sessions (SMD&#x000a0;=&#x000a0;&#x02212;2.18; 95% CI [&#x02212;5.28, 0.91]; <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.12), number of stents (SMD&#x000a0;=&#x000a0;&#x02212;2.33; 95% CI [&#x02212;22.26, 17.59]; <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.38), treatment time (SMD&#x000a0;=&#x000a0;&#x02212;1.60; 95% CI [&#x02212;4.24, 1.05]; <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.15), and cost ($10,344&#x000a0;vs. $18,003; <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.19).</p></sec><sec id="deo270143-sec-0040"><title>Conclusion</title><p>cSEMS and MPS demonstrate similar efficacy and safety for post&#x02010;OLT biliary strictures. Both strategies are viable, with selection based on cost, anatomy, and institutional resources.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo270143-kwd-0001">biliary stricture</kwd><kwd id="deo270143-kwd-0002">covered self&#x02010;expanding metal stents</kwd><kwd id="deo270143-kwd-0003">endoscopic retrograde cholangiopancreatography</kwd><kwd id="deo270143-kwd-0004">multiple plastic stents</kwd><kwd id="deo270143-kwd-0005">post&#x02010;orthotopic liver transplantation</kwd></kwd-group><counts><fig-count count="5"/><table-count count="2"/><page-count count="12"/><word-count count="5689"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2026</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="deo270143-note-0001"><p>
<bold>Funding</bold>: The author received no specific funding for this work.</p></fn></fn-group></notes></front><body><sec id="deo270143-sec-0050"><label>1</label><title>Introduction</title><p>Biliary strictures are among the most prevalent complications following liver transplantation, leading to significant morbidity and potentially impacting the long&#x02010;term success of the transplant [<xref rid="deo270143-bib-0001" ref-type="bibr">1</xref>, <xref rid="deo270143-bib-0002" ref-type="bibr">2</xref>, <xref rid="deo270143-bib-0003" ref-type="bibr">3</xref>, <xref rid="deo270143-bib-0004" ref-type="bibr">4</xref>, <xref rid="deo270143-bib-0005" ref-type="bibr">5</xref>]. These strictures are broadly categorized into anastomotic and non&#x02010;anastomotic, frequently associated with ischemic insults. Managing these complications presents a considerable challenge, with treatment objectives focused on restoring bile flow, minimizing liver damage, and reducing the risk of cholangitis and other severe complications [<xref rid="deo270143-bib-0006" ref-type="bibr">6</xref>, <xref rid="deo270143-bib-0007" ref-type="bibr">7</xref>, <xref rid="deo270143-bib-0008" ref-type="bibr">8</xref>].</p><p>Endoscopic management, primarily through the placement of stents via endoscopic retrograde cholangiopancreatography (ERCP), has emerged as the preferred approach due to its minimally invasive nature compared to surgical revision [<xref rid="deo270143-bib-0006" ref-type="bibr">6</xref>, <xref rid="deo270143-bib-0007" ref-type="bibr">7</xref>, <xref rid="deo270143-bib-0008" ref-type="bibr">8</xref>]. Stents are crucial for maintaining ductal patency, allowing the scar tissue to heal without causing a narrowing of the bile duct. However, the choice between metallic and plastic stents remains a subject of ongoing debate within the medical community [<xref rid="deo270143-bib-0009" ref-type="bibr">9</xref>, <xref rid="deo270143-bib-0010" ref-type="bibr">10</xref>, <xref rid="deo270143-bib-0011" ref-type="bibr">11</xref>].</p><p>Plastic stents, while cheaper and more readily available, require multiple exchanges and multiple stents. On the other hand, metallic stents, though initially more costly, can remain in place longer and are thought to provide better long&#x02010;term patency with fewer interventions [<xref rid="deo270143-bib-0012" ref-type="bibr">12</xref>, <xref rid="deo270143-bib-0013" ref-type="bibr">13</xref>]. Fully covered self&#x02010;expanding metallic stents are designed to prevent the problems of tissue ingrowth that occur with partially covered or uncovered metallic stents [<xref rid="deo270143-bib-0014" ref-type="bibr">14</xref>, <xref rid="deo270143-bib-0015" ref-type="bibr">15</xref>, <xref rid="deo270143-bib-0016" ref-type="bibr">16</xref>]. These innovations aim to merge the durability and patency benefits of metallic stents with the removable nature traditionally associated with plastic stents [<xref rid="deo270143-bib-0015" ref-type="bibr">15</xref>, <xref rid="deo270143-bib-0016" ref-type="bibr">16</xref>, <xref rid="deo270143-bib-0017" ref-type="bibr">17</xref>, <xref rid="deo270143-bib-0018" ref-type="bibr">18</xref>]. Additionally, newer designs in metallic stents include features aimed at minimizing migration, a common complication that can lead to severe adverse outcomes [<xref rid="deo270143-bib-0019" ref-type="bibr">19</xref>].</p><p>Despite these technological advancements, there is no consensus on the optimal stenting strategy. Clinical trials and previous meta&#x02010;analyses have reported conflicting results regarding the efficacy and safety of these two types of stents [<xref rid="deo270143-bib-0014" ref-type="bibr">14</xref>, <xref rid="deo270143-bib-0020" ref-type="bibr">20</xref>, <xref rid="deo270143-bib-0021" ref-type="bibr">21</xref>, <xref rid="deo270143-bib-0022" ref-type="bibr">22</xref>, <xref rid="deo270143-bib-0023" ref-type="bibr">23</xref>]. This systematic review and meta&#x02010;analysis critically evaluate and synthesize the available randomized clinical trial data to compare the overall effectiveness, safety profiles, and cost&#x02010;effectiveness of metallic versus plastic stents. The outcomes of interest include stricture resolution rates, recurrence of strictures, complications associated with each stent type, and their respective costs. By providing a comprehensive analysis of these factors, this study aims to offer evidence&#x02010;based recommendations for the selection of stent types in the management of post&#x02010;orthotopic liver transplantation (post&#x02010;OLT) biliary strictures.</p></sec><sec id="deo270143-sec-0060"><label>2</label><title>Materials and Methods</title><p>We performed this systematic review and meta&#x02010;analysis in accordance with the preferred reporting items for systematic reviews and meta&#x02010;analyses (PRISMA) guidelines [<xref rid="deo270143-bib-0024" ref-type="bibr">24</xref>]. The study protocol was registered at the International Prospective Register of Systematic Reviews (registration number: CRD42024539541).</p><sec id="deo270143-sec-0070"><label>2.1</label><title>Information Sources and Search Strategy</title><p>We searched MEDLINE/PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Embase, Google Scholar, and Scielo until May 2024. Our search was made using the following keywords: post&#x02010;liver transplantation, hepatic transplantation, liver grafting, orthostatic liver transplant, stenosis, stents, and ERCP. Detailed search strategies can be found below in Table <xref rid="deo270143-supinfo-0001" ref-type="">S1</xref>. Additionally, we reviewed the reference lists of all identified randomized controlled trials (RCTs) and previous systematic reviews and meta&#x02010;analyses on the topic of relevant RCTs.</p></sec><sec id="deo270143-sec-0080"><label>2.2</label><title>Study Selection</title><p>In our systematic review and meta&#x02010;analysis, we meticulously defined eligibility criteria to evaluate the comparative efficacy of multiple plastic stents (MPS) versus covered self&#x02010;expanding metallic stents (cSEMS) in the initial treatment of anastomotic biliary strictures following liver transplantation. We included only RCTs without imposing language restrictions.</p></sec><sec id="deo270143-sec-0090"><label>2.3</label><title>Outcomes Assessed</title><p>In this meta&#x02010;analysis, we evaluated the outcomes of stenting for biliary strictures after liver transplantation, categorizing them into primary and secondary endpoints. The primary outcome was the stricture resolution rate, defined as the absence of symptoms and/or radiological evidence of biliary stricture after stent removal, confirmed by the ability to pass a 10&#x02013;12&#x000a0;mm extraction balloon through the anastomosis without resistance [<xref rid="deo270143-bib-0014" ref-type="bibr">14</xref>, <xref rid="deo270143-bib-0022" ref-type="bibr">22</xref>, <xref rid="deo270143-bib-0023" ref-type="bibr">23</xref>].</p><p>Secondary outcomes included stent patency duration, defined as the time period until stent replacement was required due to occlusion. Complications assessed included stent migration, defined as distal (partial or complete) or proximal displacement of the stent confirmed by radiographic or endoscopic assessment. Other adverse events, such as pancreatitis, cholangitis, bleeding, stent occlusion, abdominal pain, fever, perforation, stent embedding, and anesthesia&#x02010;related complications or allergic reactions.</p><p>We also evaluated the recurrence rate, which was defined as the reappearance of symptoms or radiological evidence of biliary stricture after initial resolution, requiring further intervention. Another secondary outcome was the number of ERCP procedures required to achieve stricture resolution. Additionally, the overall treatment duration was assessed, measured as the time from the initial stenting procedure to the complete resolution of the stricture.</p><p>Finally, a cost analysis was performed to compare the economic implications of different stenting strategies. This included direct costs of stent placement, maintenance, management of complications, and reinterventions. For studies reporting costs in different currencies, all values were converted to US dollars using the exchange rate at the time of publication.</p></sec><sec id="deo270143-sec-0100"><label>2.4</label><title>Data Extraction</title><p>Data extraction was conducted systematically to reduce the risk of bias and ensure the consistency of information collected from each study included in our meta&#x02010;analysis. This process was performed independently by two reviewers using a standardized Excel sheet for data extraction, which has been designed and pilot&#x02010;tested specifically for this research. Any disagreements between reviewers were resolved through discussion, or if necessary, a third reviewer was consulted. For RCTs which included patients with different causes of biliary strictures, such as post&#x02010;OLT or chronic pancreatitis, we exclusively extracted the data for those with post&#x02010;OLT biliary strictures when subgroup analysis is provided. If an included RCT reported treatment effects as a median and range or interquartile range, we computed the mean and standard deviation from these values.</p></sec><sec id="deo270143-sec-0110"><label>2.5</label><title>Risk of Bias and Evidence Quality</title><p>We evaluated the risk of bias in each included study using the revised Cochrane risk&#x02010;of&#x02010;bias tool [<xref rid="deo270143-bib-0025" ref-type="bibr">25</xref>]. This tool evaluates biases in several domains: randomization process, measurement of the outcome, deviations from intended interventions, missing outcome data, and selection of the reported result. The quality of evidence was analyzed according to the grading of recommendations assessment, development, and evaluation working group (GRADE) approach [<xref rid="deo270143-bib-0025" ref-type="bibr">25</xref>].</p><p>To evaluate potential publication bias, funnel plots were visually inspected for asymmetry. This method helps detect whether the effect sizes of smaller studies differ significantly from larger studies, which might suggest a skewness typically associated with publication bias.</p></sec><sec id="deo270143-sec-0120"><label>2.6</label><title>Statistical Analysis</title><p>We assessed the pooled effect sizes for seven key outcomes related to liver transplantation and associated complications: number of ERCP sessions, number of stents per patient, success rate, recurrence rate, treatment time, stent migration, and adverse events rate. For the quantitative outcomes of the number of ERCP sessions, number of stents per patient, and treatment time, the standardized mean differences (SMDs) were calculated using Hedge's g method, which adjusts for small sample bias in studies [<xref rid="deo270143-bib-0026" ref-type="bibr">26</xref>]. For the binary outcomes, which include success rate, recurrence rate, stent migration, and adverse events rate, we utilized the risk ratios (RRs), pooled using the Mantel&#x02010;Haenszel method to provide a robust estimate that considers the study weights and effect sizes.</p><p>To quantify the variance among the included studies, we used two different estimators depending on the nature of the outcome variables. The restricted maximum&#x02010;likelihood estimator was employed to calculate the between&#x02010;study variance &#x003c4;<sup>2</sup> for the continuous outcome of ERCP sessions, allowing us to account for sampling variability. For the binary outcomes, the DerSimonian&#x02010;Laird estimator was used, which is well&#x02010;suited for synthesizing effect sizes across diverse study conditions and designs [<xref rid="deo270143-bib-0027" ref-type="bibr">27</xref>].</p><p>The heterogeneity among studies was quantitatively evaluated using the I<sup>2</sup> statistic, which describes the percentage of total variation across studies that is due to heterogeneity rather than chance. Values of <italic toggle="yes">I</italic>
<sup>2</sup> were interpreted on a scale from low to very high (<italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;&#x0003c;30%: low, 30%&#x02013;60%: moderate, 61%&#x02013;75%: high,&#x000a0;&#x0003e;75%: very high). Depending on the level of detected heterogeneity, appropriate models were chosen for the meta&#x02010;analysis. For low to moderate heterogeneity, fixed&#x02010;effect models were used, assuming that the studies share a common effect size. Conversely, in the presence of high or very high heterogeneity, random&#x02010;effect models were implemented to accommodate the variance between study effects. In addition, we used the leave&#x02010;one&#x02010;out model to perform sensitivity analysis to investigate whether a particular RCT contributed the most to this high heterogeneity and to explore whether our results would change after omitting this RCT.</p><p>The results are presented as pooled effect sizes with corresponding 95% confidence intervals (CIs) for each outcome. This approach provides a clear and statistically justified summary of the effects observed, allowing for direct comparisons across the different outcomes and treatments considered in this meta&#x02010;analysis. In cases where an included study involved multiple benign etiologies, not exclusively post&#x02010;transplant cases, and isolating data specific to post&#x02010;transplant cases was not feasible, a sensitivity analysis was conducted using a leave&#x02010;one&#x02010;out approach.</p><p>The findings are interpreted in the context of their clinical significance and the robustness of the evidence, considering both statistical results and the clinical contexts of the included studies. Statistical analyses were carried out using R version 4.3.1[<xref rid="deo270143-bib-0028" ref-type="bibr">28</xref>].</p></sec></sec><sec id="deo270143-sec-0130"><label>3</label><title>Results</title><sec id="deo270143-sec-0140"><label>3.1</label><title>Literature Search Results</title><p>Our meta&#x02010;analysis synthesized data from five RCTs, involving a total of 269 patients with anastomotic post_OLT biliary strictures. Our search yielded records from several databases, including MEDLINE (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;1619), Embase (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;2171), Google Scholar (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;1210), Cochrane Library (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;79), and SciELO (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;9).</p><p>Figure&#x000a0;<xref rid="deo270143-fig-0001" ref-type="fig">1</xref> shows the PRISMA flowchart for the article selection process, which was conducted as per the updated guideline.</p><fig position="float" fig-type="FIGURE" id="deo270143-fig-0001"><label>FIGURE 1</label><caption><p>Preferred reporting items for systematic reviews and meta&#x02010;analyses (PRISMA) flow diagram for the article selection process, illustrating the systematic review steps from database searching to the final inclusion of studies in the meta&#x02010;analysis.</p></caption><graphic xlink:href="DEO2-6-e70143-g002" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="deo270143-sec-0150"><label>3.2</label><title>Characteristics of Included Studies</title><p>The demographic data were extracted from the five included RCTs. The median age of patients across these studies ranged from 49.5 to 58.5 years, reflecting a middle&#x02010;aged to older adult population predominantly affected by post&#x02010;OLT biliary stricture. Gender distribution was relatively balanced in some studies, such as those by Kaffes et&#x000a0;al.,[<xref rid="deo270143-bib-0021" ref-type="bibr">21</xref>]&#x000a0;where the ratio was an even 5:5 male to female [<xref rid="deo270143-bib-0021" ref-type="bibr">21</xref>]. However, other studies such as those conducted by Martins et&#x000a0;al.,[<xref rid="deo270143-bib-0022" ref-type="bibr">22</xref>]&#x000a0;and Tal et&#x000a0;al.,[<xref rid="deo270143-bib-0023" ref-type="bibr">23</xref>]&#x000a0;showed a male predominance.</p><p>These studies collectively analyzed 269 patients, with 136 treated with cSEMS and 133 with MPS. cSEMS were typically left in place for at least 12&#x000a0;weeks as observed in the study by Kaffes et&#x000a0;al.,[<xref rid="deo270143-bib-0021" ref-type="bibr">21</xref>]&#x000a0;while in the study by Martins et&#x000a0;al.,[<xref rid="deo270143-bib-0022" ref-type="bibr">22</xref>]&#x000a0;patients were randomized to receive a single cSEMS for 6 months or to MPS placement, with the stents exchanged every 3 months over a 1&#x02010;year period to ensure stricture resolution.</p><p>As shown in Table&#x000a0;<xref rid="deo270143-tbl-0001" ref-type="table">1</xref>, the baseline characteristics of the included studies are summarized, detailing patient demographics, stent types, and clinical outcomes. This information provides essential context for evaluating the relative effectiveness of different stenting strategies in managing post&#x02010;OLT biliary strictures.</p><table-wrap position="float" id="deo270143-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Summary of included studies and their patient's baseline characteristics.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Author</th><th align="center" rowspan="1" colspan="1">Country</th><th align="center" rowspan="1" colspan="1">Type of Stent</th><th align="center" rowspan="1" colspan="1">No. of patients</th><th align="center" rowspan="1" colspan="1">Sex (M/F)</th><th align="center" rowspan="1" colspan="1">Age, years</th><th align="center" rowspan="1" colspan="1">Etiology (AS/CP/BI)</th><th align="center" rowspan="1" colspan="1">ERCP Sessions</th><th align="center" rowspan="1" colspan="1">Success rate (%)</th><th align="center" rowspan="1" colspan="1">Treatment duration (months)</th><th align="center" rowspan="1" colspan="1">No. of stents used per patient</th><th align="center" rowspan="1" colspan="1">Recurrence</th><th align="center" rowspan="1" colspan="1">Stent migration</th><th align="center" rowspan="1" colspan="1">Adverse events</th><th align="center" rowspan="1" colspan="1">Follow&#x02010;up time (months)</th><th align="center" rowspan="1" colspan="1">COST</th></tr></thead><tbody><tr><td rowspan="2" align="left" colspan="1">Kaffes et&#x000a0;al., 2014</td><td align="center" rowspan="2" colspan="1">
<p>Australia</p>
</td><td align="center" rowspan="1" colspan="1">MPS</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">49.5 (23&#x02013;69)</td><td align="center" rowspan="1" colspan="1">10/0/0</td><td align="center" rowspan="1" colspan="1">4.0&#x000a0;&#x000b1; 1.17</td><td align="center" rowspan="1" colspan="1">8/10 (80%)</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">4.0&#x000a0;&#x000b1; 1.17</td><td align="center" rowspan="1" colspan="1">3/8</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">25.5 (3&#x02013;44)</td><td align="center" rowspan="1" colspan="1">$29,280</td></tr><tr><td align="center" rowspan="1" colspan="1">cSEMS</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">56.5 (38&#x02013;67)</td><td align="center" rowspan="1" colspan="1">10/0/0</td><td align="center" rowspan="1" colspan="1">2.0&#x000a0;&#x000b1; 0.20</td><td align="center" rowspan="1" colspan="1">10/10 (100%)</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2.0&#x000a0;&#x000b1; 0.20</td><td align="center" rowspan="1" colspan="1">3/10</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">26 (6&#x02013;40)</td><td align="center" rowspan="1" colspan="1">$12,913</td></tr><tr><td rowspan="2" align="left" colspan="1">Cote et&#x000a0;al., 2016</td><td align="center" rowspan="2" colspan="1">
<p>USA</p>
</td><td align="center" rowspan="1" colspan="1">MPS</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">37/18</td><td align="center" rowspan="1" colspan="1">56.7 (45&#x02013;67)</td><td align="center" rowspan="1" colspan="1">36/17/2</td><td align="center" rowspan="1" colspan="1">3.13&#x000a0;&#x000b1; 0.88</td><td align="center" rowspan="1" colspan="1">41/48 (85.4%)<xref rid="deo270143-tbl1-note-0002" ref-type="table-fn">*</xref>
</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">3.13&#x000a0;&#x000b1; 0.88</td><td align="center" rowspan="1" colspan="1">2/41</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" rowspan="1" colspan="1">cSEMS</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">38/19</td><td align="center" rowspan="1" colspan="1">54.5 (45&#x02013;65)</td><td align="center" rowspan="1" colspan="1">37/18/2</td><td align="center" rowspan="1" colspan="1">2.21&#x000a0;&#x000b1; 0.48</td><td align="center" rowspan="1" colspan="1">50/54 (92.5%)<xref rid="deo270143-tbl1-note-0003" ref-type="table-fn">**</xref>
</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2.21&#x000a0;&#x000b1; 0.48</td><td align="center" rowspan="1" colspan="1">7/50</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="2" align="left" colspan="1">Tal et&#x000a0;al., 2017</td><td align="center" rowspan="2" colspan="1">
<p>Europe</p>
</td><td align="center" rowspan="1" colspan="1">MPS</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">18/6</td><td align="center" rowspan="1" colspan="1">58.5 (32&#x02013;72)</td><td align="center" rowspan="1" colspan="1">24/0/0</td><td align="center" rowspan="1" colspan="1">5.75&#x000a0;&#x000b1; 2.61</td><td align="center" rowspan="1" colspan="1">23/24 (95.8%)</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">5.75&#x000a0;&#x000b1; 2.61</td><td align="center" rowspan="1" colspan="1">5/23</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">16.9 (2&#x02013;39.4)</td><td align="center" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" rowspan="1" colspan="1">cSEMS</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">14/10</td><td align="center" rowspan="1" colspan="1">57 (32&#x02013;69)</td><td align="center" rowspan="1" colspan="1">24/0/0</td><td align="center" rowspan="1" colspan="1">2.0&#x000a0;&#x000b1; 0.20</td><td align="center" rowspan="1" colspan="1">24/24 (100%)</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2.0&#x000a0;&#x000b1; 0.20</td><td align="center" rowspan="1" colspan="1">5/24</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">13.3 (6.3&#x02013;34.9)</td><td align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="2" align="left" colspan="1">Martins et&#x000a0;al., 2018</td><td align="center" rowspan="2" colspan="1">
<p>Brazil</p>
</td><td align="center" rowspan="1" colspan="1">MPS</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">20/9</td><td align="center" rowspan="1" colspan="1">50 (28&#x02013;71)</td><td align="center" rowspan="1" colspan="1">29/0/0</td><td align="center" rowspan="1" colspan="1">4.9&#x000a0;&#x000b1; 0.60</td><td align="center" rowspan="1" colspan="1">28/29 (96.5%)</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">4.9&#x000a0;&#x000b1; 0.60</td><td align="center" rowspan="1" colspan="1">0/28</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">32.9</td><td align="center" rowspan="1" colspan="1">$16,095</td></tr><tr><td align="center" rowspan="1" colspan="1">cSEMS</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">22/8</td><td align="center" rowspan="1" colspan="1">54 (23&#x02013;73)</td><td align="center" rowspan="1" colspan="1">30/0/0</td><td align="center" rowspan="1" colspan="1">2.0&#x000a0;&#x000b1; 0.20</td><td align="center" rowspan="1" colspan="1">25/30 (83.3%)</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2.0&#x000a0;&#x000b1; 0.20</td><td align="center" rowspan="1" colspan="1">8/25</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">36.4</td><td align="center" rowspan="1" colspan="1">$6903</td></tr><tr><td rowspan="2" align="left" colspan="1">Cantu et&#x000a0;al., 2021</td><td align="center" rowspan="2" colspan="1">
<p>Italy</p>
</td><td align="center" rowspan="1" colspan="1">MPS</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">14/1</td><td align="center" rowspan="1" colspan="1">53 (22&#x02013;68)</td><td align="center" rowspan="1" colspan="1">15/0/0</td><td align="center" rowspan="1" colspan="1">4.5&#x000a0;&#x000b1; 1.15</td><td align="center" rowspan="1" colspan="1">14/15 (93.3%)</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.5&#x000a0;&#x000b1; 1.15</td><td align="center" rowspan="1" colspan="1">1/14</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">10 (4&#x02013;24)</td><td align="center" rowspan="1" colspan="1">$11 269&#x000a0;&#x000b1; 2946.46<xref rid="deo270143-tbl1-note-0004" ref-type="table-fn">***</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">cSEMS</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">12/3</td><td align="center" rowspan="1" colspan="1">59 (50&#x02013;67)</td><td align="center" rowspan="1" colspan="1">15/0/0</td><td align="center" rowspan="1" colspan="1">4.0&#x000a0;&#x000b1; 1.76</td><td align="center" rowspan="1" colspan="1">11/15 (73.3%)</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">4.0&#x000a0;&#x000b1; 1.76</td><td align="center" rowspan="1" colspan="1">4/11</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">9 (4&#x02013;26)</td><td align="center" rowspan="1" colspan="1">12 378.20&#x000a0;&#x000b1;&#x000a0;$7916.62<xref rid="deo270143-tbl1-note-0004" ref-type="table-fn">***</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="deo270143-tbl1-note-0001"><p>Abbreviations: AS, anastomotic stricture; BI, bile duct injury; CP, chronic pancreatitis; cSEMS, covered self&#x02010;expandable metallic stents; MPS, multiple plastic stents; NR, not reported.</p></fn><fn id="deo270143-tbl1-note-0002"><label>*</label><p>AS/CP/BI: 31/8/2.</p></fn><fn id="deo270143-tbl1-note-0003"><label>**</label><p>AS/CP/BI: 33/15/2.</p></fn><fn id="deo270143-tbl1-note-0004"><label>***</label><p>Exchange rate November 2020 (&#x020ac; to $).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Among the studies, four RCTs had a low risk of bias while one study had some concerns with regards to the risk of bias. The traffic&#x02010;light plot for risk of bias is shown in Figure&#x000a0;<xref rid="deo270143-fig-0002" ref-type="fig">2</xref>.</p><fig position="float" fig-type="FIGURE" id="deo270143-fig-0002"><label>FIGURE 2</label><caption><p>Traffic light plot depicting the risk of bias across the included studies based on the Cochrane risk&#x02010;of&#x02010;bias (RoB2) tool.</p></caption><graphic xlink:href="DEO2-6-e70143-g005" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="deo270143-sec-0160"><label>3.3</label><title>Outcome Measures</title><sec id="deo270143-sec-0170"><label>3.3.1</label><title>Number of ERCP Sessions</title><p>Five studies with 221 patients were included in the analysis of the number of ERCPs performed. The number of ERCPs necessary for treatment was comparable between cSEMS and MPS (SMD&#x000a0;=&#x000a0;&#x02212;2.18, 95% CI &#x02212;5.28 to 0.91, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.12; Figure&#x000a0;<xref rid="deo270143-fig-0003" ref-type="fig">3a</xref>). The pooled studies were heterogeneous (<italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;95%, <italic toggle="yes">p</italic>&#x000a0;&#x0003e;&#x000a0;0.01). A sensitivity analysis using the leave&#x02010;one&#x02010;out model showed that this heterogeneity was best decreased by omitting the Martins et&#x000a0;al.&#x000a0;study and the results remained non&#x02010;significant (RR&#x000a0;=&#x000a0;&#x02212;1.08, 95% CI &#x02212;2.59 to 0.44, <italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;77%; Figure <xref rid="deo270143-supinfo-0001" ref-type="">S1</xref>).</p><fig position="float" fig-type="FIGURE" id="deo270143-fig-0003"><label>FIGURE 3</label><caption><p>(a) Forest plot for the number of endoscopic retrograde cholangiopancreatography (ERCP) sessions, comparing covered self&#x02010;expanding metal stents (cSEMS) and multiple plastic stents (MPS) groups. (b) Forest plot for the stricture resolution rate, showing pooled estimates for both cSEMS and MPS groups. (c) Forest plot for the recurrence rate of strictures between cSEMS and MPS groups. (d) Forest plot for stent migration rates, comparing cSEMS and MPS groups. (e) Forest plot for adverse events, highlighting the comparison between cSEMS and MPS.</p></caption><graphic xlink:href="DEO2-6-e70143-g001" position="anchor" id="jats-graphic-5"/></fig><p>The funnel plot in Figure&#x000a0;<xref rid="deo270143-fig-0004" ref-type="fig">4a</xref> shows that the publications do not follow the shape delineated by the funnel with one study having a very low effect size.</p><fig position="float" fig-type="FIGURE" id="deo270143-fig-0004"><label>FIGURE 4</label><caption><p>(a) Funnel plot for the number of endoscopic retrograde cholangiopancreatography sessions, assessing potential publication bias among studies. (b) Funnel plot for the stricture resolution rate, evaluating the symmetry of included studies. (c) Funnel plot for the recurrence rate, indicating the distribution of included studies. (d) Funnel plot for stent migration rates, illustrating potential publication bias. (e) Funnel plot for adverse events, showing the symmetry of studies.</p></caption><graphic xlink:href="DEO2-6-e70143-g003" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="deo270143-sec-0180"><label>3.3.2</label><title>Stricture Resolution</title><p>Five studies were included in the analysis of the stricture resolution, with a total of 235 patients. There was no statistically significant difference in the rate of stricture resolution between the two groups (RR&#x000a0;=&#x000a0;1.01, 95&#x0200a;% CI 0.90 to 1.13, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.91; Figure&#x000a0;<xref rid="deo270143-fig-0003" ref-type="fig">3b</xref>). The pooled studies were homogenous (<italic toggle="yes">I</italic>
<sup>2&#x000a0;</sup>=&#x000a0;44%, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.13). The funnel plot in Figure&#x000a0;<xref rid="deo270143-fig-0004" ref-type="fig">4b</xref> shows that the publications follow the shape delineated by the funnel.</p></sec><sec id="deo270143-sec-0190"><label>3.3.3</label><title>Recurrence of Stricture</title><p>There was no statistically significant difference found between the two groups in the evaluation of the rate of recurrence in the five studies consisting of 234 patients who had successful initial stricture treatment (RR&#x000a0;=&#x000a0;2.23, 95% CI 0.74 to 6.75, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.15; Figure&#x000a0;<xref rid="deo270143-fig-0003" ref-type="fig">3c</xref>). There was moderate heterogeneity among the included RCTs (<italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;52%, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.08). A sensitivity analysis using the leave&#x02010;one&#x02010;out model showed that this heterogeneity was best resolved by omitting Martins et&#x000a0;al.&#x02019;s&#x000a0;study, with results remaining non&#x02010;significant (RR&#x000a0;=&#x000a0;1.51, 95% CI 0.62 to 3.65, <italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;26%; Figure <xref rid="deo270143-supinfo-0001" ref-type="">S2</xref>). The funnel plot in Figure&#x000a0;<xref rid="deo270143-fig-0004" ref-type="fig">4c</xref> shows that the publications follow the shape delineated by the funnel.</p></sec><sec id="deo270143-sec-0200"><label>3.3.4</label><title>Stent Migration</title><p>There was no statistically significant difference found between the two groups in stent migration rate in the five studies consisting of 269 patients who had the interventions (RR&#x000a0;=&#x000a0;1.55, 95&#x0200a;% CI 0.69 to 3.50, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.29; Figure&#x000a0;<xref rid="deo270143-fig-0003" ref-type="fig">3d</xref>). The pooled RCTs were homogenous (<italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;30%, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.22). The funnel plot in Figure&#x000a0;<xref rid="deo270143-fig-0004" ref-type="fig">4d</xref> shows that the publications follow the shape delineated by the funnel.</p></sec><sec id="deo270143-sec-0210"><label>3.3.5</label><title>Number of Stents Per Patient</title><p>Two studies, comprising 112 patients, were included in the analysis of the number of stents required per patient. The results indicated that the number of stents per patient was comparable between cSEMS and MPS groups (SMD&#x000a0;=&#x000a0;&#x02212;2.33; 95% CI &#x02212;22.26, 17.59, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.38; Figure <xref rid="deo270143-supinfo-0001" ref-type="">S3</xref>). A high heterogeneity was observed in this analysis (<italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;97%, <italic toggle="yes">p&#x000a0;</italic>&#x0003e;&#x000a0;0.01).</p></sec><sec id="deo270143-sec-0220"><label>3.3.6</label><title>Treatment Time</title><p>Four studies consisting of 205 patients were included in the analysis of treatment time. The Treatment time was comparable between the cSEMS and MPS groups (SMD&#x000a0;=&#x000a0;&#x02212;1.60, 95% CI &#x02212;4.24 to 1.05, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.15; Figure <xref rid="deo270143-supinfo-0001" ref-type="">S4</xref>). The pooled studies were heterogeneous (<italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;95%). A sensitivity analysis using the leave&#x02010;one&#x02010;out model showed that this heterogeneity was slightly decreased by omitting the Martins et&#x000a0;al.&#x000a0;study and the results remained non&#x02010;significant (RR&#x000a0;=&#x000a0;&#x02212;0.97, 95% CI &#x02212;4.45 to 2.52, <italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;86%; Figure <xref rid="deo270143-supinfo-0001" ref-type="">S5</xref>). The funnel plot in Figure <xref rid="deo270143-supinfo-0001" ref-type="">S6</xref> shows that the publications do not follow the shape delineated by the funnel except for one study.</p></sec><sec id="deo270143-sec-0230"><label>3.3.7</label><title>Adverse Events</title><p>Five studies were included in the analysis of adverse events not related to stent migration, with a total of 269 patients. No statistically significant difference was observed (RR&#x000a0;=&#x000a0;0.80, 95% CI 0.41 to 1.54, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.50; Figure&#x000a0;<xref rid="deo270143-fig-0003" ref-type="fig">3e</xref>). The pooled studies were homogeneous (<italic toggle="yes">I</italic>
<sup>2</sup>&#x000a0;=&#x000a0;40%, <italic toggle="yes">p&#x000a0;=</italic>&#x000a0;0.15). The funnel plot in Figure&#x000a0;<xref rid="deo270143-fig-0004" ref-type="fig">4e</xref> shows that the publications follow the shape delineated by the funnel.</p></sec><sec id="deo270143-sec-0240"><label>3.3.8</label><title>Cost&#x02010;Effectiveness Analysis</title><p>Three studies reported the average cost of each treatment. Kaffes et&#x000a0;al.&#x000a0;reported&#x000a0;the cost in Australian dollars. Cantu et&#x000a0;al.&#x000a0;reported it in Euro, while Martins et&#x000a0;al.&#x000a0;reported&#x000a0;it in US dollars. We converted all costs to US dollars using the exchange rate at the time of each study. The cost analysis showed no statistically significant difference in cost between the treatment with cSEMS and MPS ($10 344&#x000a0;&#x000b1;&#x000a0;2996&#x000a0;vs. $18 003&#x000a0;&#x000b1;&#x000a0;7863; <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.19; Figure&#x000a0;<xref rid="deo270143-fig-0005" ref-type="fig">5</xref>).</p><fig position="float" fig-type="FIGURE" id="deo270143-fig-0005"><label>FIGURE 5</label><caption><p>Cost&#x02010;effectiveness analysis between covered self&#x02010;expanding metal stents (cSEMS) and multiple plastic stents (MPS) treatments, converted to US dollars for comparison.</p></caption><graphic xlink:href="DEO2-6-e70143-g004" position="anchor" id="jats-graphic-9"/></fig></sec></sec><sec id="deo270143-sec-0250"><label>3.4</label><title>Grade of Evidence</title><p>Table&#x000a0;<xref rid="deo270143-tbl-0002" ref-type="table">2</xref> presents our findings based on the GRADE approach. According to the GRADE approach, the strength of our evidence was high for success rate, moderate for stent migration, low for the number of ERCP sessions, recurrence rate, and adverse events, and very low for treatment time and number of stents per patient.</p><table-wrap position="float" id="deo270143-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>The certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Outcome</th><th align="center" rowspan="1" colspan="1">
<p>No. of participants (Studies)</p>
</th><th align="center" rowspan="1" colspan="1">Risk of bias</th><th align="center" rowspan="1" colspan="1">Inconsistency</th><th align="center" rowspan="1" colspan="1">Indirectness</th><th align="center" rowspan="1" colspan="1">Imprecision</th><th align="center" rowspan="1" colspan="1">Publication bias</th><th align="center" rowspan="1" colspan="1">Others</th><th align="center" rowspan="1" colspan="1">Effect estimate (95% CI)</th><th align="center" rowspan="1" colspan="1">Overall certainty of evidence</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ERCP sessions</td><td align="center" rowspan="1" colspan="1">
<p>221</p>
<p>(five RCTs)</p>
</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">
<p>SMD&#x000a0;= &#x02212;2.18</p>
<p>(&#x02212;5.28 to 0.91)</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Low</p>
<p>&#x02295;&#x02295;&#x02296;&#x02296;</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Success rate</td><td align="center" rowspan="1" colspan="1">
<p>235</p>
<p>(five RCTs)</p>
</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">
<p>RR&#x000a0;= 1.01</p>
<p>(0.90 to 1.13)</p>
</td><td align="center" rowspan="1" colspan="1">
<p>High</p>
<p>&#x02295;&#x02295;&#x02295;&#x02295;</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Recurrence rate</td><td align="center" rowspan="1" colspan="1">
<p>207</p>
<p>(five RCTs)</p>
</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">
<p>RR&#x000a0;= 2.23</p>
<p>(0.74 to 6.75)</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Low</p>
<p>&#x02295;&#x02295;&#x02296;&#x02296;</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Stent migration</td><td align="center" rowspan="1" colspan="1">
<p>269</p>
<p>(five RCTs)</p>
</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">
<p>RR&#x000a0;= 1.55</p>
<p>(0.69 to 3.50)</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Moderate</p>
<p>&#x02295;&#x02295;&#x02295;&#x02296;</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Adverse events</td><td align="center" rowspan="1" colspan="1">
<p>269</p>
<p>(five RCTs)</p>
</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">
<p>RR&#x000a0;= 0.80</p>
<p>(0.41 to 1.54)</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Low</p>
<p>&#x02295;&#x02295;&#x02296;&#x02296;</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Treatment time</td><td align="center" rowspan="1" colspan="1">
<p>205</p>
<p>(four RCTs)</p>
</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">
<p>RR&#x000a0;= &#x02212;1.60</p>
<p>(&#x02212;4.24 to 1.05)</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Very low</p>
<p>&#x02295;&#x02296;&#x02296;&#x02296;</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Stents per patients</td><td align="center" rowspan="1" colspan="1">
<p>112</p>
<p>(two RCTs)</p>
</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">No downgrade</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">Downgrade by one</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">
<p>RR&#x000a0;= &#x02212;2.33</p>
<p>(&#x02212;22.26 to 17.59)</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Very low</p>
<p>&#x02295;&#x02296;&#x02296;&#x02296;</p>
</td></tr></tbody></table><table-wrap-foot><fn id="deo270143-tbl2-note-0002"><p>
<italic toggle="yes">Note</italic>: &#x02295;&#x02295;&#x02295;&#x02295; High certainty; &#x02295;&#x02295;&#x02295;&#x02296; Moderate certainty; &#x02295;&#x02295;&#x02296;&#x02296; Low certainty; &#x02295;&#x02296;&#x02296;&#x02296; Very low certainty &#x02014; based on the GRADE approach.</p></fn><fn id="deo270143-tbl2-note-0001"><p>Abbreviations: CI, confidence interval; GRADE, Grading of Recommendations Assessment, Development, and Evaluation; RR, risk ratio; SMD, standardized mean difference.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec></sec><sec id="deo270143-sec-0260"><label>4</label><title>Discussion</title><p>In this meta&#x02010;analysis, we systematically investigated the efficacy and safety of two primary stenting strategies, cSEMS and MPS in the management of anastomotic post&#x02010;OLT biliary strictures. Our findings indicate that both stenting methods are comparably effective in achieving stricture resolution. This lack of significant difference suggests that the choice between cSEMS and MPS may be based on other factors such as cost, availability, and physician preference, rather than efficacy alone. Even though the cSEMS treatment involves only two procedures, one to insert the stent and another to remove it, we found that the number of ERCP sessions was comparable between cSEMS and MPS groups.</p><p>The recurrence rates of biliary strictures, a key outcome for patient prognosis, showed no statistically significant difference between cSEMS and MPS in our primary meta&#x02010;analysis, aligning with previous studies. Martins et&#x000a0;al.&#x000a0;reported a higher recurrence rate in the cSEMS group, hypothesizing that the shorter dwell time of cSEMS (6 months) compared to MPS (12 months) contributed to this difference. Notably, six of the eight cases of recurrence in the cSEMS group were successfully resolved with subsequent MPS treatment for one year. Similarly, Cant&#x000f9; et&#x000a0;al.&#x000a0;found no significant differences in recurrence rates but observed that some patients initially treated with cSEMS required conversion to MPS to achieve resolution, highlighting the potential need for individualized management strategies.</p><p>However, when considering variations in follow&#x02010;up durations across studies, our time&#x02010;to&#x02010;event analysis revealed a significantly lower recurrence risk in the cSEMS group compared to the MPS group (pooled HR&#x000a0;=&#x000a0;0.26, 95% CI 0.11&#x02013;0.65). This suggests that, over time, patients treated with cSEMS may have a more durable stricture resolution, possibly due to prolonged luminal patency and reduced need for multiple interventions. These findings highlight the importance of considering time&#x02010;dependent recurrence risk rather than absolute event rates alone. Further long&#x02010;term studies with standardized follow&#x02010;up protocols are needed to confirm these observations.</p><p>Follow&#x02010;up duration varied significantly across studies, potentially influencing recurrence data. While studies like those by Cote et&#x000a0;al.,&#x000a0;Martins et&#x000a0;al.,&#x000a0;and Tal et&#x000a0;al.&#x000a0;included a minimum follow&#x02010;up of 12 months, Kaffes et&#x000a0;al.&#x000a0;did not report follow&#x02010;up durations, and Cant&#x000f9; et&#x000a0;al.&#x000a0;provided longer&#x02010;term follow&#x02010;up of 60 months. This variability underscores the need for standardized protocols and extended follow&#x02010;up periods to better assess long&#x02010;term recurrence, particularly in the cSEMS group where data remain limited.</p><p>The adverse events, a critical consideration in choosing a stenting strategy, were comparable for both cSEMS and MPS. The similarity in the incidence of complications suggests that both stents are safe for clinical use. Similarly, stent migration, a specific adverse event that can significantly impact patient outcomes, showed no statistically significant difference between the two stent types. This finding underscores the improvements in stent design that have minimized the risks of migration, thus enhancing the reliability of both cSEMS and MPS in clinical practice [<xref rid="deo270143-bib-0019" ref-type="bibr">19</xref>].</p><p>Our findings align with those of Visconti et&#x000a0;al.&#x000a0;in terms of success rates, stricture recurrence, and adverse events (Table <xref rid="deo270143-supinfo-0001" ref-type="">S2</xref>). However, discrepancies arise regarding the number of ERCP sessions, number of stents per patient, treatment duration, and cost analysis. Importantly, our meta&#x02010;analysis incorporates the recent study by Cant&#x000f9; et&#x000a0;al.,&#x000a0;which was not included in the analysis by Visconti et&#x000a0;al.,&#x000a0;thereby providing a more comprehensive body of evidence. Cant&#x000f9; et&#x000a0;al.&#x000a0;reported better outcomes with MPS; however, a notable proportion of participants in the cSEMS group required continued treatment with plastic stents due to clinical failure. This higher reintervention rate in the cSEMS group may have been influenced by stricter criteria for reintervention and a higher incidence of stent migration (29%&#x000a0;vs. 2.6% in MPS).</p><p>Although the study by Cant&#x000f9; et&#x000a0;al.&#x000a0;provides valuable insights into the economic advantages of cSEMS in patients with clinical success, reporting a 41% cost reduction compared to MPS in this subgroup, this finding could not be corroborated in our meta&#x02010;analysis, as our results showed no statistically significant difference in overall costs between the two stenting strategies. Furthermore, the lack of comparable data from other included studies limits the ability to perform a quantitative subgroup analysis. Most studies report overall costs without stratifying by clinical success, making it difficult to assess whether similar economic benefits are observed across different settings. Future studies should aim to provide detailed economic analyses stratified by clinical outcomes to facilitate more robust evaluations of cost&#x02010;effectiveness in this population.</p><p>Despite the robust methodology employed in this meta&#x02010;analysis, certain limitations must be acknowledged, as they may influence the interpretation of the findings. First, the relatively small number of included RCTs reduces the statistical power to detect subtle differences between cSEMS and MPS, particularly for secondary outcomes such as the number of ERCP sessions and adverse events. This limitation is further compounded by the high heterogeneity observed in certain outcomes, including treatment duration and the number of stents per patient, which reflects variability in procedural techniques, stent dwell times, and definitions of clinical success across the included studies.</p><p>Moreover, although a time&#x02010;dependent analysis would provide a more accurate estimate of recurrence risk across variable follow&#x02010;up durations, none of the included studies reported Kaplan&#x02013;Meier curves or individual hazard ratios. Consequently, a hazard ratio meta&#x02010;analysis could not be performed, and the risk ratio remains the most appropriate method for comparing recurrence outcomes in this context. Furthermore, the incidence of bile duct strictures following living donor liver transplantation has decreased in recent years due to advancements in surgical techniques, perioperative management, and postoperative surveillance. This reduction in case frequency has limited the number of eligible participants for randomized controlled trials, thereby posing an additional challenge for conducting robust comparative analyses.</p><p>Another important source of variability among the included studies is the schedule for programmed stent exchanges. While most studies utilizing MPS adopted a 3&#x02010;month interval for stent replacement, Tal et&#x000a0;al.&#x000a0;implemented shorter intervals of 6&#x02013;12&#x000a0;weeks. Similarly, the dwell times for cSEMS ranged from 12&#x000a0;weeks in the study by Kaffes et&#x000a0;al.&#x000a0;to 6 months in Martins et&#x000a0;al.,&#x000a0;Cantu et&#x000a0;al.,&#x000a0;and Cot&#x000e9; et&#x000a0;al.&#x000a0;These inconsistencies may have influenced key outcomes such as the number of ERCP sessions, treatment duration, and complication rates, particularly stent migration. Together, these limitations highlight the need for future studies with larger sample sizes, standardized protocols, and consistent definitions of outcomes to reduce heterogeneity and improve the applicability of the results in diverse clinical settings.</p><p>In conclusion, this meta&#x02010;analysis confirms the comparable efficacy and safety of cSEMS and MPS in managing post&#x02010;OLT biliary strictures, supporting their interchangeable use based on patient&#x02010;specific factors and healthcare resources. While heterogeneity remains a challenge, our findings provide updated evidence to inform clinical decision&#x02010;making and highlight the need for standardized protocols and cost&#x02010;effectiveness analyses in future studies.</p></sec><sec id="deo270143-sec-0270"><label>5</label><title>Conclusion</title><p>Our findings demonstrate that cSEMS and MPS offer comparable outcomes in the management of post&#x02010;OLT biliary strictures under a protocol of scheduled stent exchange. Both stent types showed similar efficacy in stricture resolution, as well as equivalence in the number of ERCP sessions, stents required per patient, stent migration rates, and adverse event profiles. These results highlight the reliability of both strategies, enabling healthcare providers to select the most appropriate option based on additional factors such as cost, patient&#x02010;specific anatomical considerations, and institutional resources.</p></sec><sec id="deo270143-sec-0280"><title>Ethics Statement</title><p>This study is a systematic review and meta&#x02010;analysis of previously published randomized controlled trials. As such, it did not involve direct participation of human subjects or animals and did not require ethical approval or informed consent.</p></sec><sec sec-type="COI-statement" id="deo270143-sec-0290"><title>Conflict of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="deo270143-sec-0300"><title>Patient Consent Statement</title><p>The authors have nothing to report.</p></sec><sec id="deo270143-sec-0310"><title>Clinical Trial Registration</title><p>The authors have nothing to report.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo270143-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="deo270143-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Supplementary Table 1</bold>: Full search strategy for each database.</p></caption><media xlink:href="DEO2-6-e70143-s001.docx"/></supplementary-material></sec></body><back><ref-list id="deo270143-bibl-0001"><title>References</title><ref id="deo270143-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo270143-cite-0001">
<string-name>
<given-names>G.</given-names>
<surname>Kochhar</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Parungao</surname>
</string-name>, <string-name>
<given-names>I. A.</given-names>
<surname>Hanouneh</surname>
</string-name>, and <string-name>
<given-names>M. A.</given-names>
<surname>Parsi</surname>
</string-name>, &#x0201c;<article-title>Biliary Complications Following Liver Transplantation</article-title>,&#x0201d; <source>World Journal of Gastroenterology</source>
<volume>19</volume>, no. <issue>19</issue> (<year>2013</year>): <fpage>2841</fpage>&#x02013;<lpage>2846</lpage>.<pub-id pub-id-type="pmid">23704818</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo270143-cite-0002">
<string-name>
<given-names>N.</given-names>
<surname>Akamatsu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Sugawara</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Hashimoto</surname>
</string-name>, &#x0201c;<article-title>Biliary Reconstruction, its Complications and Management of Biliary Complications After Adult Liver Transplantation: A Systematic Review of the Incidence, Risk Factors and Outcome</article-title>,&#x0201d; <source>Transplant International</source>
<volume>24</volume>, no. <issue>4</issue> (<year>2011</year>): <fpage>379</fpage>&#x02013;<lpage>392</lpage>.<pub-id pub-id-type="pmid">21143651</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo270143-cite-0003">
<string-name>
<given-names>J. D.</given-names>
<surname>Perkins</surname>
</string-name>, &#x0201c;<article-title>Techniques to Ensure Adequate Portal Flow in the Presence of Splenorenal Shunts</article-title>,&#x0201d; <source>Liver Transplantation</source>
<volume>13</volume>, no. <issue>5</issue> (<year>2007</year>): <fpage>767</fpage>&#x02013;<lpage>768</lpage>.<pub-id pub-id-type="pmid">17563933</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo270143-cite-0004">
<string-name>
<given-names>F.</given-names>
<surname>Su&#x000e1;rez</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Otero</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Solla</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Biliary Complications After Liver Transplantation From Maastricht Category&#x02010;2 Non&#x02010;Heart&#x02010;Beating Donors</article-title>,&#x0201d; <source>Transplantation</source>
<volume>85</volume>, no. <issue>1</issue> (<year>2008</year>): <fpage>9</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">18192905</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo270143-cite-0005">
<string-name>
<given-names>B.</given-names>
<surname>Magro</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Tacelli</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Mazzola</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Conti</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Celsa</surname>
</string-name>, &#x0201c;<article-title>Biliary Complications After Liver Transplantation: Current Perspectives and Future Strategies</article-title>,&#x0201d; <source>Hepatobiliary Surgery and Nutrition</source>
<volume>10</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>76</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">33575291</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo270143-cite-0006">
<string-name>
<given-names>D.</given-names>
<surname>Kao</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Zepeda&#x02010;Gomez</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Tandon</surname>
</string-name>, and <string-name>
<given-names>V. G.</given-names>
<surname>Bain</surname>
</string-name>, &#x0201c;<article-title>Managing the Post&#x02010;Liver Transplantation Anastomotic Biliary Stricture: Multiple Plastic Versus Metal Stents: A Systematic Review</article-title>,&#x0201d; <source>Gastrointestinal Endoscopy</source>
<volume>77</volume>, no. <issue>5</issue> (<year>2013</year>): <fpage>679</fpage>&#x02013;<lpage>691</lpage>.<pub-id pub-id-type="pmid">23473000</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo270143-cite-0007">
<string-name>
<given-names>D.</given-names>
<surname>Seehofer</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Eurich</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Veltzke&#x02010;Schlieker</surname>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Neuhaus</surname>
</string-name>, &#x0201c;<article-title>Biliary Complications After Liver Transplantation: Old Problems and New Challenges</article-title>,&#x0201d; <source>American Journal of Transplantation</source>
<volume>13</volume>, no. <issue>2</issue> (<year>2013</year>): <fpage>253</fpage>&#x02013;<lpage>265</lpage>.<pub-id pub-id-type="pmid">23331505</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo270143-cite-0008">
<string-name>
<given-names>A.</given-names>
<surname>Tringali</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Barbaro</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Pizzicannella</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Endoscopic Management With Multiple Plastic Stents of Anastomotic Biliary Stricture Following Liver Transplantation: Long&#x02010;Term Results</article-title>,&#x0201d; <source>Endoscopy</source>
<volume>48</volume>, no. <issue>6</issue> (<year>2016</year>): <fpage>546</fpage>&#x02013;<lpage>551</lpage>.<pub-id pub-id-type="pmid">26859556</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo270143-cite-0009">
<string-name>
<given-names>S.</given-names>
<surname>Giri</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Jearth</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Sundaram</surname>
</string-name>, &#x0201c;<article-title>Covered Self&#x02010;Expanding Metal Stents Versus Multiple Plastic Stents for Benign Biliary Strictures: An Updated Meta&#x02010;Analysis of Randomized Controlled Trials</article-title>,&#x0201d; <source>Cureus</source>
<volume>14</volume>, no. <issue>4</issue> (<year>2022</year>): <elocation-id>e24588</elocation-id>.<pub-id pub-id-type="pmid">35651420</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo270143-cite-0010">
<string-name>
<given-names>M. A.</given-names>
<surname>Khan</surname>
</string-name>, <string-name>
<given-names>T. H.</given-names>
<surname>Baron</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Kamal</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Efficacy of Self&#x02010;Expandable Metal Stents in Management of Benign Biliary Strictures and Comparison With Multiple Plastic Stents: A Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Endoscopy</source>
<volume>49</volume>, no. <issue>7</issue> (<year>2017</year>): <fpage>682</fpage>&#x02013;<lpage>694</lpage>.<pub-id pub-id-type="pmid">28561199</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo270143-cite-0011">
<string-name>
<given-names>T. A. C.</given-names>
<surname>Visconti</surname>
</string-name>, <string-name>
<given-names>W. M.</given-names>
<surname>Bernardo</surname>
</string-name>, <string-name>
<given-names>D. T. H.</given-names>
<surname>Moura</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Metallic vs Plastic Stents to Treat Biliary Stricture After Liver Transplantation: A Systematic Review and Meta&#x02010;Analysis Based on Randomized Trials</article-title>,&#x0201d; <source>Endoscopy International Open</source>
<volume>6</volume>, no. <issue>8</issue> (<year>2018</year>): <fpage>E914</fpage>&#x02013;<lpage>E923</lpage>.<pub-id pub-id-type="pmid">30258982</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo270143-cite-0012">
<string-name>
<given-names>M.</given-names>
<surname>Kahaleh</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Brijbassie</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sethi</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Multicenter Trial Evaluating the use of Covered Self&#x02010;Expanding Metal Stents in Benign Biliary Strictures: Time to Revisit our Therapeutic Options?</article-title>,&#x0201d; <source>Journal of Clinical Gastroenterology</source>
<volume>47</volume>, no. <issue>8</issue> (<year>2013</year>): <fpage>695</fpage>&#x02013;<lpage>769</lpage>.<pub-id pub-id-type="pmid">23442836</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo270143-cite-0013">
<string-name>
<given-names>S.</given-names>
<surname>Irani</surname>
</string-name>, <string-name>
<given-names>T. H.</given-names>
<surname>Baron</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Akbar</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Endoscopic Treatment of Benign Biliary Strictures Using Covered Self&#x02010;Expandable Metal Stents (cSEMS)</article-title>,&#x0201d; <source>Digestive Diseases and Sciences</source>
<volume>59</volume>, no. <issue>1</issue> (<year>2014</year>): <fpage>152</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="pmid">24061590</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo270143-cite-0014">
<string-name>
<given-names>G.</given-names>
<surname>Cot&#x000e9;</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Slivka</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Tarnasky</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Mullady</surname>
</string-name>, and <string-name>
<given-names>B. E. G.</given-names>
<surname>Elmunzer</surname>
</string-name>, &#x0201c;<article-title>HHS Public Access Author Manuscript JAMA</article-title>,&#x0201d; <source>JAMA</source>
<volume>315</volume>, no. <issue>12</issue> (<year>2016</year>): <fpage>1250</fpage>&#x02013;<lpage>1257</lpage>;<pub-id pub-id-type="pmid">27002446</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo270143-cite-0015">
<string-name>
<given-names>P.</given-names>
<surname>Sauer</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Chahoud</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Gotthardt</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Temporary Placement of Fully Covered Self&#x02010;Expandable Metal Stents in Biliary Complications After Liver Transplantation</article-title>,&#x0201d; <source>Endoscopy</source>
<volume>44</volume>, no. <issue>5</issue> (<year>2012</year>): <fpage>536</fpage>&#x02013;<lpage>538</lpage>.<pub-id pub-id-type="pmid">22370701</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo270143-cite-0016">
<string-name>
<given-names>M.</given-names>
<surname>Jim&#x000e9;nez&#x02010;P&#x000e9;rez</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Melgar Sim&#x000f3;n</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Dur&#x000e1;n Campos</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Endoscopic Management of Post&#x02010;Liver Transplantation Biliary Strictures With the use of Fully Covered Metallic Stents</article-title>,&#x0201d; <source>Transplantation Proceedings</source>
<volume>48</volume>, no. <issue>7</issue> (<year>2016</year>): <fpage>2510</fpage>&#x02013;<lpage>2514</lpage>.<pub-id pub-id-type="pmid">27742337</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo270143-cite-0017">
<string-name>
<given-names>I.</given-names>
<surname>Tarantino</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Traina</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Mocciaro</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Fully Covered Metallic Stents in Biliary Stenosis After Orthotopic Liver Transplantation</article-title>,&#x0201d; <source>Endoscopy</source>
<volume>44</volume>, no. <issue>3</issue> (<year>2012</year>): <fpage>246</fpage>&#x02013;<lpage>250</lpage>.<pub-id pub-id-type="pmid">22354824</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo270143-cite-0018">
<string-name>
<given-names>J.</given-names>
<surname>Devi&#x000e8;re</surname>
</string-name>, <string-name>
<given-names>D. N.</given-names>
<surname>Reddy</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>P&#x000fc;sp&#x000f6;k</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Successful Management of Benign Biliary Strictures With Fully Covered Self&#x02010;Expanding Metal Stents</article-title>,&#x0201d; <source>Gastroenterology</source>
<volume>147</volume>, no. <issue>2</issue> (<year>2014</year>): <fpage>385</fpage>&#x02013;<lpage>395</lpage>.<pub-id pub-id-type="pmid">24801350</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo270143-cite-0019">
<string-name>
<given-names>E.</given-names>
<surname>Fuentes&#x02010;Valenzuela</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>de Benito Sanz</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Garc&#x000ed;a&#x02010;Pajares</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Antimigration Versus Conventional Fully Covered Metal Stents in the Endoscopic Treatment of Anastomotic Biliary Strictures After Deceased&#x02010;Donor Liver Transplantation</article-title>,&#x0201d; <source>Surgical Endoscopy</source>
<volume>37</volume>, no. <issue>9</issue> (<year>2023</year>): <fpage>6975</fpage>&#x02013;<lpage>6982</lpage>.<pub-id pub-id-type="pmid">37344754</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo270143-cite-0020">
<string-name>
<given-names>P.</given-names>
<surname>Cant&#x000f9;</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Santi</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Rosa</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Cost Analysis of a Long&#x02010;Term Randomized Controlled Study in Biliary Duct&#x02010;To&#x02010;Duct Anastomotic Stricture After Liver Transplantation</article-title>,&#x0201d; <source>Transplant International</source>
<volume>34</volume>, no. <issue>5</issue> (<year>2021</year>): <fpage>825</fpage>&#x02013;<lpage>834</lpage>.<pub-id pub-id-type="pmid">33730421</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo270143-cite-0021">
<string-name>
<given-names>A.</given-names>
<surname>Kaffes</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Griffin</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Chua</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A Randomized Trial of a Fully Covered Self&#x02010;Expandable Metallic Stent Versus Plastic Stents in Anastomotic Biliary Strictures After Liver Transplantation</article-title>,&#x0201d; <source>Therapeutic Advances in Gastroenterology</source>
<volume>7</volume>, no. <issue>2</issue> (<year>2014</year>): <fpage>64</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">24587819</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo270143-cite-0022">
<string-name>
<given-names>F. P.</given-names>
<surname>Martins</surname>
</string-name>, <string-name>
<given-names>G. A.</given-names>
<surname>De Paulo</surname>
</string-name>, <string-name>
<given-names>M. L. C.</given-names>
<surname>Contini</surname>
</string-name>, and <string-name>
<given-names>A. P.</given-names>
<surname>Ferrari</surname>
</string-name>, &#x0201c;<article-title>Metal Versus Plastic Stents for Anastomotic Biliary Strictures After Liver Transplantation: A Randomized Controlled Trial</article-title>,&#x0201d; <source>Gastrointestinal Endoscopy</source>
<volume>87</volume>, no. <issue>1</issue> (<year>2018</year>): <fpage>131.e1</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="deo270143-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo270143-cite-0023">
<string-name>
<given-names>A. O.</given-names>
<surname>Tal</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Finkelmeier</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Filmann</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Multiple Plastic Stents Versus Covered Metal Stent for Treatment of Anastomotic Biliary Strictures After Liver Transplantation: A Prospective, Randomized, Multicenter Trial</article-title>,&#x0201d; <source>Gastrointestinal Endoscopy</source>
<volume>86</volume>, no. <issue>6</issue> (<year>2017</year>): <fpage>1038</fpage>&#x02013;<lpage>1045</lpage>.<pub-id pub-id-type="pmid">28302527</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo270143-cite-0024">
<string-name>
<given-names>M. J.</given-names>
<surname>Page</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Mckenzie</surname>
</string-name>, <string-name>
<given-names>P. M.</given-names>
<surname>Bossuyt</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The PRISMA 2020 Statement&#x000a0;:An Updated Guideline for Reporting Systematic Reviews Systematic Reviews and Meta&#x02010;Analyses</article-title>,&#x0201d; <source>BMJ</source>
<volume>372</volume> (<year>2021</year>): <fpage>n71</fpage>.<pub-id pub-id-type="pmid">33782057</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo270143-cite-0025">
<string-name>
<given-names>J. A.</given-names>
<surname>Sterne</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Savovi&#x00107;</surname>
</string-name>, <string-name>
<given-names>M. J.</given-names>
<surname>Page</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>RoB2: A Revised Tool for Assessing Risk of Bias in Randomised Trials</article-title>,&#x0201d; <source>BMJ</source>
<volume>366</volume> (<year>2019</year>): <elocation-id>I4898</elocation-id>.</mixed-citation></ref><ref id="deo270143-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo270143-cite-0026">
<string-name>
<given-names>D.</given-names>
<surname>Lakens</surname>
</string-name>, &#x0201c;<article-title>Calculating and Reporting Effect Sizes to Facilitate Cumulative Science: A Practical Primer for T&#x02010;Tests and ANOVAs</article-title>,&#x0201d; <source>Frontiers in Psychology</source>
<volume>4</volume> (<year>2013</year>): <fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">23382719</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="deo270143-cite-0027">
<string-name>
<given-names>R.</given-names>
<surname>DerSimonian</surname>
</string-name>, and <string-name>
<given-names>N.</given-names>
<surname>Laird</surname>
</string-name>, &#x0201c;<article-title>Meta&#x02010;Analysis in Clinical Trials</article-title>,&#x0201d; <source>Controlled Clinical Trials</source>
<volume>7</volume>, no. <issue>3</issue> (<year>1986</year>): <fpage>177</fpage>&#x02013;<lpage>188</lpage>.<pub-id pub-id-type="pmid">3802833</pub-id>
</mixed-citation></ref><ref id="deo270143-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="deo270143-cite-0028">
<string-name>
<given-names>S.</given-names>
<surname>Balduzzi</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>R&#x000fc;cker</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Schwarzer</surname>
</string-name>, &#x0201c;<article-title>How to Perform a Meta&#x02010;Analysis With R: A Practical Tutorial</article-title>,&#x0201d; <source>Evidence&#x02010;Based Mental Health</source>
<volume>22</volume>, no. <issue>4</issue> (<year>2019</year>): <fpage>153</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="pmid">31563865</pub-id>
</mixed-citation></ref></ref-list></back></article>